Page 31 - ட்ரெக்செல் பல்கலைக்கழகம் கல்லூரி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana
COVID-19 news: Pa , N J coronavirus cases, deaths rise; vaccine, stimulus updates
inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.
A humidifier could help ward off COVID-19, but don t overdo it
inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.
Covid dating: A shopping guide to help you safely date
nbcnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcnews.com Daily Mail and Mail on Sunday newspapers.
Share:
PITTSBURGH, Dec. 11, 2020 /PRNewswire-PRWeb/ Cynthia Hundorfean, President and CEO of Allegheny Health Network (AHN), has been selected by Modern Healthcare magazine as one of 2020 s 100 Most Influential People.
This prestigious recognition acknowledges and honors individuals who are deemed by their peers and the senior editors of Modern Healthcare to be the most influential leaders in the industry.
In being honored as one of Modern Healthcare s 100 Most Influential People, Ms. Hundorfean joins prominent leaders from across the United States, including elected officials, government appointees, health system CEOs, insurance industry presidents, and representatives from retail health care.
The complete ranking can be found in this week s issue of Modern Healthcare magazine, and a feature article and profiles of the winners are available at ModernHealthcare.com/100MostInfluential.
When Will Coronavirus Vaccine Be Available In US? FDA Advisers Recommend Pfizer Vaccine Approval
KEY POINTS
The FDA is expected to grant approval this week
Operation Warp Speed could begin distributing vaccines early next week
A panel of experts from the U.S. Food and Drug Administration on Thursday formally recommended Pfizer and BioNTech’s coronavirus vaccine for approval, paving the way for mass vaccinations to begin early next week.
The FDA’s vaccine advisory panel composed of scientific experts, infectious disease doctors, and statisticians voted 17 to 4 in favor of emergency use authorization after an eight-hour deliberation. The FDA is expected to grant approval on Saturday, sources familiar with the discussion told The New York Times.